Suchergebnisse - "Yi, Xiao-Ming"

PubPharm (15)

1

Application of 1470 nm semiconductor laser in the treatment of benign prostatic hyperplasia in ultra-aged patients

enthalten in: Zhonghua nan ke xue = National journal of andrology | 2023

von Wu, D. | Yi, X. | Wei, H. | +5

2

"Scarless" circumcision technique retaining original appearance

enthalten in: Zhonghua nan ke xue = National journal of andrology | 2023

von Yi, X. | Wu, D. | Shi, X. | +5

3

Long-term effect of finasteride on high-risk patients with benign prostatic hyperplasia after implantation of thermo-expandable spiral prostatic stent

enthalten in: Zhonghua nan ke xue = National journal of andrology | 2022

von Yi, X. | He, H. | Xu, S. | +5

4

Clinicopathologic features of testicular seminoma with syncytiotrophoblastic cells : Analysis of 3 cases and review of the literature

enthalten in: Zhonghua nan ke xue = National journal of andrology | 2019

von Liang, Y. | Tu, P. | Wang, X. | +3

5

Spiral thermo-expandable prostatic stent implantation for benign prostatic hyperplasia : Clinical analysis of 26 cases

enthalten in: Zhonghua nan ke xue = National journal of andrology | 2019

von He, H. | Yi, X. | Xu, S. | +6

6

Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma

enthalten in: European urology | 2018

von Qu, L. | Wang, Z. | Chen, Q. | +29

CommentIn: Eur Urol. 2018 Dec;74(6):764-766. - PMID 30177289

7

miR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma

enthalten in: Molecular medicine reports | 2016

von Xu, S. | Yi, X. | Zhang, Z. | +2

8

Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma

enthalten in: Oncology reports | 2016

von Xu, S. | Yi, X. | Tang, C. | +3

9

Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma

enthalten in: Oncology reports | 2016

von XU, S. | YI, X. | TANG, C. | +3

10

Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer

enthalten in: International journal of clinical and experimental pathology | 2015

von Xu, S. | Yi, X. | Zhou, W. | +3